Bisphosphonates First for Osteoporosis; Youth T2D to Surge 700%; Insulin Cap Limits

Use bisphosphonates for the initial pharmacologic treatment of primary osteoporosis in men and postmenopausal women, the American College of Physicians recommended in its updated guidelines. (Annals of Internal Medicine)

Detection of elevated uric acid levels prior to 24 weeks gestation was linked with a higher risk of gestational diabetes development, an observational study found. (Journal of Clinical Endocrinology & Metabolism)

If current trends continue, the incidence of type 1 and type 2 diabetes in youth are expected to increase by 65% and 673%, respectively, by the year 2060. (Diabetes Care)

As it only applies to Medicare recipients, most Americans with diabetes won't benefit from the Inflation Reduction Act's $35 cap on monthly out-of-pocket costs for insulin, which went into effect on January 1. (NBC News)

People carrying ARRB1 gene variants may benefit from earlier initiation of GLP-1 receptor agonists, according to a genome-wide pharmacogenomic study. (The Lancet Diabetes & Endocrinology)

Told she wouldn't survive to adulthood due to her type 1 diabetes, this 92-year-old from South Africa defied the odds, becoming a doctor along the way. (Washington Post)

In newly diagnosed multiple sclerosis (MS), obesity was associated with higher disease severity and worse outcomes over time, though not with relapse rates. (Journal of Neurology, Neurosurgery & Psychiatry)

Arizona's departing attorney general filed a civil complaint against a local thyroid drug tablet manufacturer for allegedly misleading customers by falsely advertising the amount of active ingredients (liothyronine and levothyroxine) in its drugs. (KTAR News)

Comment